UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Factor VIII gene (F8) mutations as predictors of outcome in immune tolerance induction of hemophilia A patients with high‐responding inhibitors

Journal of thrombosis and haemostasis, 2009-11, Vol.7 (11), p.1809-1815

2009

Volltextzugriff (PDF)

Source and purity of factor VIII products as risk factors for inhibitor development in patients with hemophilia A

Journal of thrombosis and haemostasis, 2012-05, Vol.10 (5), p.781-790

2012

Volltextzugriff (PDF)

Low dose of aPCC after the initial treatment in acquired haemophilia A is useful to reduce bleeding relapses: Data from the FAIR registry

Thrombosis research, 2019-02, Vol.174, p.24-26

2019

Volltextzugriff (PDF)

Non-genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus report

Haemophilia : the official journal of the World Federation of Hemophilia, 2010-09, Vol.16 (5), p.747-766

2010

Volltextzugriff (PDF)

Current view and outcome of ITI therapy - A change over time?

Thrombosis research, 2016-12, Vol.148, p.38-44

2016

Volltextzugriff (PDF)

Mortality and causes of death in Italian persons with haemophilia, 1990-2007

Haemophilia : the official journal of the World Federation of Hemophilia, 2010-05, Vol.16 (3), p.437-446

2010

Volltextzugriff (PDF)

Health-related quality of life in patients with haemophilia and inhibitors on prophylaxis with anti-inhibitor complex concentrate: results from the Pro-FEIBA study

Haemophilia : the official journal of the World Federation of Hemophilia, 2013-09, Vol.19 (5), p.736-743

2013

Volltextzugriff (PDF)

Immune tolerance induction in patients with haemophilia a and inhibitors: effectiveness and cost analysis in an European Cohort (The ITER Study)

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-01, Vol.22 (1), p.96-102

2016

Volltextzugriff (PDF)

Combined use of antifibrinolytics and activated prothrombin complex concentrate (aPCC) is not related to thromboembolic events in patients with acquired haemophilia A: data from FAIR Registry

Journal of thrombosis and thrombolysis, 2019-01, Vol.47 (1), p.129-133

2019

Volltextzugriff (PDF)

A prospective randomized trial of high and standard dosages of recombinant factor VIIa for treatment of hemarthroses in hemophiliacs with inhibitors

Journal of thrombosis and haemostasis, 2006-02, Vol.4 (2), p.367-371

2006

Volltextzugriff (PDF)

Neonatal bleeding in haemophilia: a European cohort study

British journal of haematology, 2012-02, Vol.156 (3), p.374-382

2012

Volltextzugriff (PDF)

Recommendations for assessment, monitoring and follow-up of patients with haemophilia

Haemophilia : the official journal of the World Federation of Hemophilia, 2012-05, Vol.18 (3), p.319-325

2012

Volltextzugriff (PDF)

Inhibitors in haemophilia B: the Italian experience

Haemophilia : the official journal of the World Federation of Hemophilia, 2013-09, Vol.19 (5), p.686-690

2013

Volltextzugriff (PDF)

Intracranial haemorrhage in the Italian population of haemophilia patients with and without inhibitors

Haemophilia : the official journal of the World Federation of Hemophilia, 2012-01, Vol.18 (1), p.39-45

2012

Volltextzugriff (PDF)

A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study)

Journal of thrombosis and haemostasis, 2011-04, Vol.9 (4), p.700-710

2011

Volltextzugriff (PDF)

Current European practice in immune tolerance induction therapy in patients with haemophilia and inhibitors

Haemophilia : the official journal of the World Federation of Hemophilia, 2006-07, Vol.12 (4), p.363-371

2006

Volltextzugriff (PDF)

Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors

Thrombosis and haemostasis, 2001-10, Vol.86 (4), p.954-958

2001

Volltextzugriff (PDF)

Perceived challenges and attitudes to regimen and product selection from Italian haemophilia treaters: the 2013 AICE survey

Haemophilia : the official journal of the World Federation of Hemophilia, 2014-03, Vol.20 (2), p.e128-e135

2014

Volltextzugriff (PDF)

PSY26 Costs and Outcomes of Patients With Haemophilia a (HA) and Factor VIII Inhibitors Treatment: The Immune Tolerance and Economics Retrospective Registry (ITER) Results

Value in health, 2012-06, Vol.15 (4), p.A103-A103

2012

Volltextzugriff (PDF)

Prenatal diagnosis of haemophilia B: the Italian experience

Haemophilia : the official journal of the World Federation of Hemophilia, 2013-11, Vol.19 (6), p.898-903

2013

Volltextzugriff (PDF)

Development of an inhibitor-specific questionnaire for the assessment of health-related quality of life in haemophilia patients with inhibitors (INHIB-QoL)

Value in health, 2013-05, Vol.16 (3), p.A196-A196

2013

Volltextzugriff (PDF)

Current use of by-passing agents in Europe in the management of acute bleeds in patients with haemophilia and inhibitors

Haemophilia : the official journal of the World Federation of Hemophilia, 2007-01, Vol.13 (1), p.38-45

2007

Volltextzugriff (PDF)

Health status and quality of life of elderly persons with severe hemophilia born before the advent of modern replacement therapy

Journal of thrombosis and haemostasis, 2009-05, Vol.7 (5), p.780-786

2009

Volltextzugriff (PDF)

Mutational spectrum of F8 gene and prothrombotic gene variants in haemophilia A patients from Southern Italy

Haemophilia : the official journal of the World Federation of Hemophilia, 2008-07, Vol.14 (4), p.796-803

2008

Volltextzugriff (PDF)

Literature review of surgery management in inhibitor patients

Haemophilia : the official journal of the World Federation of Hemophilia, 2004-09, Vol.10 (s2), p.22-29

2004

Volltextzugriff (PDF)

1 – 25 von 154

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(146)
Mit Volltextzugriff
(132)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Factor VIII gene (F8) mutations as predictors of outcome in immune tolerance induction of hemophilia A patients with high‐responding inhibitors

Source and purity of factor VIII products as risk factors for inhibitor development in patients with hemophilia A

Low dose of aPCC after the initial treatment in acquired haemophilia A is useful to reduce bleeding relapses: Data from the FAIR registry

Non-genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus report

Current view and outcome of ITI therapy - A change over time?

Mortality and causes of death in Italian persons with haemophilia, 1990-2007

Health-related quality of life in patients with haemophilia and inhibitors on prophylaxis with anti-inhibitor complex concentrate: results from the Pro-FEIBA study

Immune tolerance induction in patients with haemophilia a and inhibitors: effectiveness and cost analysis in an European Cohort (The ITER Study)

Combined use of antifibrinolytics and activated prothrombin complex concentrate (aPCC) is not related to thromboembolic events in patients with acquired haemophilia A: data from FAIR Registry

A prospective randomized trial of high and standard dosages of recombinant factor VIIa for treatment of hemarthroses in hemophiliacs with inhibitors

Neonatal bleeding in haemophilia: a European cohort study

Recommendations for assessment, monitoring and follow-up of patients with haemophilia

Inhibitors in haemophilia B: the Italian experience

Intracranial haemorrhage in the Italian population of haemophilia patients with and without inhibitors

A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study)

Current European practice in immune tolerance induction therapy in patients with haemophilia and inhibitors

Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors

Perceived challenges and attitudes to regimen and product selection from Italian haemophilia treaters: the 2013 AICE survey

PSY26 Costs and Outcomes of Patients With Haemophilia a (HA) and Factor VIII Inhibitors Treatment: The Immune Tolerance and Economics Retrospective Registry (ITER) Results

Prenatal diagnosis of haemophilia B: the Italian experience

Development of an inhibitor-specific questionnaire for the assessment of health-related quality of life in haemophilia patients with inhibitors (INHIB-QoL)

Current use of by-passing agents in Europe in the management of acute bleeds in patients with haemophilia and inhibitors

Health status and quality of life of elderly persons with severe hemophilia born before the advent of modern replacement therapy

Mutational spectrum of F8 gene and prothrombotic gene variants in haemophilia A patients from Southern Italy

Literature review of surgery management in inhibitor patients

Suchergebnisse filtern